PubRank

R L Carithers

Author PubWeight™ 44.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med 1995 2.83
2 Fulminant hepatic failure: summary of a workshop. Hepatology 1995 2.53
3 Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995 1.74
4 Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 1998 1.46
5 The natural history of untreated focal allograft rejection in liver transplant recipients. Liver Transpl Surg 1996 1.38
6 Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 1997 1.37
7 Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. J Virol 2000 1.32
8 Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996 1.31
9 A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995 1.24
10 Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1998 1.17
11 Hepatocellular carcinoma. Hepatology 1998 1.16
12 Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997 1.10
13 In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease. J Virol 2000 1.09
14 Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997 1.09
15 Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepat 2000 1.06
16 Detection of hepatitis C virus RNA: comparison of one-stage polymerase chain reaction (PCR) with nested-set PCR. J Clin Microbiol 1993 1.04
17 Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival. Gastrointest Endosc 1998 1.04
18 Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. Am J Pathol 1993 1.03
19 Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1999 0.91
20 Infection complicating percutaneous liver biopsy in liver transplant recipients. Hepatology 1997 0.88
21 Predictors of bile leaks after T-tube removal in orthotopic liver transplant recipients. Liver Transpl Surg 1998 0.88
22 Cholestasis and alcoholic liver disease. Clin Liver Dis 1999 0.87
23 Regenerating nodules in cirrhosis: sonographic appearance with anatomic correlation. AJR Am J Roentgenol 1986 0.86
24 The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon. J Infect Dis 2000 0.85
25 Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology 1997 0.85
26 Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection. J Clin Microbiol 1983 0.83
27 Follow-up after liver transplantation for protoporphyric liver disease. Liver Transpl Surg 1996 0.83
28 Influence of polymorphic N-acetyltransferase phenotype on the inhibition and induction of acetaminophen bioactivation with long-term isoniazid. Clin Pharmacol Ther 1997 0.82
29 Primary hepatocellular carcinoma after orthotopic liver transplantation for chronic hepatitis B infection. Ann Intern Med 1991 0.81
30 Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann Intern Med 1982 0.80
31 Quantitative studies of the hepatitis B viral pre-S proteins: lack of correlation with the HBeAg status. J Virol Methods 1987 0.80
32 Hepatitis B and transplantation. Infect Dis Clin North Am 1995 0.80
33 Fatal hepatic necrosis associated with parenteral gold therapy. Dig Dis Sci 1988 0.79
34 Nuclear changes in hepatocytes of patients with non-A, non-B hepatitis. Gastroenterology 1981 0.79
35 Renal disease in hepatitis C-positive liver transplant recipients. Transplantation 1997 0.78
36 Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 1998 0.78
37 Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. Clin Transplant 1997 0.78
38 Maternal hemodynamics and pregnancy outcome in women with prior orthotopic liver transplantation. Liver Transpl 2000 0.77
39 Evaluation of postprandial serum bile acid response as a test of hepatic function. Dig Dis Sci 1986 0.77
40 Chronic non-A, non-B hepatitis: ultrastructural and serologic studies. Hepatology 1982 0.77
41 Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C. Aliment Pharmacol Ther 2007 0.76
42 The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. Hepatology 1999 0.75
43 Determination of immunoglobulin M antibodies against hepatitis B core antigen and hepatitis A virus by reorienting sucrose gradient high-speed centrifugation for diagnosis of acute viral-hepatitis. J Clin Microbiol 1981 0.75
44 Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis. Br J Clin Pharmacol 1994 0.75
45 Acetaminophen overdose. Am J Psychiatry 1978 0.75
46 Hepatitis C in clinical practice. J Intern Med 2001 0.75
47 Recovery of bile secretion following orthotopic liver transplantation. J Hepatol 1991 0.75
48 Association of human hepatocellular membrane fusions with non-A, non-B hepatitis. Virchows Arch B Cell Pathol Incl Mol Pathol 1986 0.75
49 Evaluation of the portal venous system before liver transplantation: value of phase-contrast MR angiography. AJR Am J Roentgenol 1995 0.75
50 Liver transplantation. Va Med 1986 0.75
51 Treatment of chronic hepatitis C virus infection: a clinical and virological perspective. Adv Exp Med Biol 1996 0.75
52 Viral hepatitis: prevention and prophylaxis. Va Med 1979 0.75
53 Liver transplantation in Virginia. Va Med Q 1990 0.75
54 Hepatitis C virus in renal disease. Curr Opin Nephrol Hypertens 1994 0.75
55 Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. Am J Gastroenterol 2000 0.75